Sanofi SA (SAN) Given a €91.00 Price Target at Morgan Stanley
Other equities research analysts also recently issued reports about the stock. Kepler Capital Markets set a €89.00 ($93.68) price target on shares of Sanofi SA and gave the company a buy rating in a research note on Thursday, August 11th. JPMorgan Chase & Co. set a €71.00 ($74.74) target price on shares of Sanofi SA and gave the stock a sell rating in a research note on Thursday, September 15th. Jefferies Group set a €76.00 ($80.00) target price on shares of Sanofi SA and gave the stock a neutral rating in a research note on Tuesday, September 13th. Berenberg Bank set a €93.00 ($97.89) target price on shares of Sanofi SA and gave the stock a buy rating in a research note on Thursday, September 8th. Finally, Societe Generale set a €100.00 ($105.26) target price on shares of Sanofi SA and gave the stock a buy rating in a research note on Monday, August 1st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. Sanofi SA currently has a consensus rating of Hold and an average price target of €84.00 ($88.42).
Sanofi SA (EPA:SAN) opened at 76.47 on Tuesday. The stock has a market cap of €98.42 billion and a PE ratio of 23.46. The firm has a 50 day moving average of €25.50 and a 200-day moving average of €25.74. Sanofi SA has a 12-month low of €62.50 and a 12-month high of €84.81.
About Sanofi SA
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Stock Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related stocks with our FREE daily email newsletter.